Related Experiment Video
Updated: May 9, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Posterior reversible encephalopathy syndrome in immunocompromised children - A single-center study from South India
Sudeep Gaddam1, Rajesh Kodandapani2, Nikhita Mani2
1Department of Pediatric Hematology Oncology, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India.
Insights
Posterior reversible encephalopathy syndrome (PRES) in pediatric hematology oncology patients often presents with hypertension and neurological symptoms. Early recognition and blood pressure management are crucial for these immunosuppressed children.
Area of Science:
- Pediatric Neurology
- Hematology Oncology
- Neuroimaging
Background:
- Posterior reversible encephalopathy syndrome (PRES) is a neurological condition.
- Immunosuppression in pediatric hematology oncology patients is a risk factor.
- Understanding PRES in this specific population is vital for timely diagnosis and management.
Purpose of the Study:
- To describe the clinical profile of children diagnosed with PRES in a pediatric hematology oncology unit.
- To highlight the specific clinical features of PRES in immunosuppressed children.
- To emphasize the importance of considering PRES in the differential diagnosis of neurological symptoms in this cohort.
Main Methods:
- Retrospective study of 10 children diagnosed with PRES.
- Analysis of clinical features, neuroimaging findings, and treatment outcomes.
- Focus on patients within a pediatric hematology oncology setting.
Main Results:
- The mean age of affected children was 6.8 years.
- Acute lymphoblastic leukemia and post-hematopoietic stem cell transplant were common primary diagnoses.
- Hypertension was universal at diagnosis, with bilateral parietal and occipital lobe lesions on neuroimaging.
Conclusions:
- Hypertension is a key feature of PRES in pediatric hematology oncology patients.
- Prompt recognition of PRES is essential for prompt management, including blood pressure control.
- Considering PRES in children with neurological symptoms like seizures and headaches can lead to earlier diagnosis.
Abstract:
This study describes the profile of children diagnosed with posterior reversible encephalopathy syndrome (PRES) in the pediatric hematology oncology unit and highlights the clinical features of PRES in immunosuppressed children. This retrospective study included 10 children diagnosed with PRES with a mean age of 6.8 years. Acute lymphoblastic leukemia was the most common primary diagnosis followed by post-hematopoietic stem cell transplant patients. Most cases of PRES occurred within one month of treatment initiation. Hypertension was noted in all at the time of diagnosis. Neuroimaging revealed bilateral lesions with parietal and occipital lobe involvement being the most common. All patients received corticosteroids as part of treatment for primary diagnosis. Controlling blood pressure was critical in managing PRES. Consideration of PRES as a clinical possibility in pediatric hematology oncology unit in children presenting with symptoms such as headache, seizures, and visual disturbances will aid in early diagnosis after ruling out other causes of these symptoms.
More Related Videos
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Arboviral Encephalitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Brain Abscess l: Introduction
Cerebral Edema ll: Pathophysiology

